Fertility Research

strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home/tcmlorne/public_html/modules/views/plugins/views_plugin_style_default.inc on line 0.
Recurrent pregnancy losses, a lasting cause of infertility Recurrent pregnancy loss (RPL), defined as two to three spontaneous pregnancy terminations occurring before 12 weeks of gestation, affects approximately 1% of the general population. The causes may include congenital factors that originate with the quality of the gametes (sperm or oocyte) or the...
The Appraisal of Body Content (ABC) trial: increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes To investigate the impact of obesity as determined by bioelectric impedance analysis (BIA) and body mass index (BMI) on in vitro fertilization (IVF) laboratory and clinical outcomes.
Counting follicles to define polycystic ovary morphology: should we change the way we do it? Since the Rotterdam consensus in 2003, the ultrasound aspect of polycystic ovary morphology (PCOM) has been part of the diagnostic classification of polycystic ovary syndrome (PCOS), in association with at least 1 of the 2 items “oligo-anovulation” and “hyperandrogenism.” At the time, the official...
Minimum standards for practices offering assisted reproductive technologies: a committee opinion This document is designed to provide a framework for assisted reproductive technology (ART) programs that meet or exceed the requirements suggested by the Centers for Disease Control and Prevention for certification of ART laboratories. This document replaces the document “Revised Minimum Standards...
In the article In the article by Fawzy, et al. “Humid versus dry incubator: a prospective, randomized, controlled trial” (Fertil Steril 2017;108:277-83), there is a typo in the footnote of Table 1 and a mistake in Table 3. In Table 1, the values beside the means are the midpoints of the confidence intervals (CI)...
Ovulation induction with therapeutic donor sperm insemination in fertile patients: perhaps less is more The field of assisted reproduction has broadened and diversified its scope beyond classic infertility. It now incorporates reproductive care for a wide variety of patients seeking help with nontraditional family building. Both the American Society for Reproductive Medicine and the American College...
Is it time to revisit follicle-stimulating hormone therapy in men with azoospermia? Although follicle-stimulating hormone (FSH) is necessary for male fertility, its pharmacologic use in infertile men has remained limited. Outside the use of recombinant or purified FSH therapy in hypogonadotropic hypogonadism, the use of therapeutic FSH remains controversial (1, 2). Several meta-...
How to provide improved care for deep endometriosis—the patient’s view For women in fertile age and diagnosed with deep endometriosis (DE), there is seldom a cure, just better or worse options. The prevalence of DE is estimated to be 2%–10% for the general population of fertile women and considerably higher in the group of women with infertility problems (1). Several...
First-line IVF or surgery for infertile women with bowel endometriosis? Endometriosis infiltrates the colorectal muscularis propria in about one-tenth of patients with the disease (1, 2). When women with bowel endometriosis are infertile, it is unclear whether first-line in vitro fertilization (IVF) or surgery including intestinal procedures is the most effective...
COVID-19 Pandemic and Reproductive Health This is an introduction to a Views and Reviews devoted to understanding the effects of the virus SARS-CoV-2 and COVID-19 infection on human reproductive health